These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16787147)

  • 1. Automated high content screening for phosphoinositide 3 kinase inhibition using an AKT 1 redistribution assay.
    Wolff M; Haasen D; Merk S; Kroner M; Maier U; Bordel S; Wiedenmann J; Nienhaus GU; Valler M; Heilker R
    Comb Chem High Throughput Screen; 2006 Jun; 9(5):339-50. PubMed ID: 16787147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct activation of the epithelial Na(+) channel by phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,4-bisphosphate produced by phosphoinositide 3-OH kinase.
    Tong Q; Gamper N; Medina JL; Shapiro MS; Stockand JD
    J Biol Chem; 2004 May; 279(21):22654-63. PubMed ID: 15028718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
    Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
    J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of G-protein coupled receptor desensitization-related beta-arrestin redistribution using confocal and non-confocal imaging.
    Haasen D; Wolff M; Valler MJ; Heilker R
    Comb Chem High Throughput Screen; 2006 Jan; 9(1):37-47. PubMed ID: 16454685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the phosphoinositide 3-kinase/protein kinase B signaling pathway in insulin/IGF-I-induced chondrogenesis of the mouse embryonal carcinoma-derived cell line ATDC5.
    Hidaka K; Kanematsu T; Takeuchi H; Nakata M; Kikkawa U; Hirata M
    Int J Biochem Cell Biol; 2001 Nov; 33(11):1094-103. PubMed ID: 11551825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profiling of chemokine receptor-directed compounds using high-content screening.
    Haasen D; Merk S; Seither P; Martyres D; Hobbie S; Heilker R
    J Biomol Screen; 2008 Jan; 13(1):40-53. PubMed ID: 18227225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activation.
    Marine S; Zamiara E; Smith ST; Stec EM; McGarvey J; Kornienko O; Jiang G; Wong KK; Stack JH; Zhang BB; Ferrer M; Strulovici B
    Anal Biochem; 2006 Aug; 355(2):267-77. PubMed ID: 16797469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway.
    Subramaniam S; Shahani N; Strelau J; Laliberté C; Brandt R; Kaplan D; Unsicker K
    J Neurosci; 2005 Mar; 25(11):2838-52. PubMed ID: 15772344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I induces proliferation and migration of porcine trophectoderm cells through multiple cell signaling pathways, including protooncogenic protein kinase 1 and mitogen-activated protein kinase.
    Jeong W; Song G; Bazer FW; Kim J
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):175-84. PubMed ID: 24508636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of phospholipase D in insulin-like growth factor-I-induced activation of extracellular signal-regulated kinase, but not phosphoinositide 3-kinase or Akt, in Chinese hamster ovary cells.
    Banno Y; Takuwa Y; Yamada M; Takuwa N; Ohguchi K; Hara A; Nozawa Y
    Biochem J; 2003 Jan; 369(Pt 2):363-8. PubMed ID: 12385647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endomembrane PtdIns(3,4,5)P3 activates the PI3K-Akt pathway.
    Jethwa N; Chung GH; Lete MG; Alonso A; Byrne RD; Calleja V; Larijani B
    J Cell Sci; 2015 Sep; 128(18):3456-65. PubMed ID: 26240177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
    Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
    Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane.
    Ivetac I; Munday AD; Kisseleva MV; Zhang XM; Luff S; Tiganis T; Whisstock JC; Rowe T; Majerus PW; Mitchell CA
    Mol Biol Cell; 2005 May; 16(5):2218-33. PubMed ID: 15716355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct regulatory mechanisms of neurotransmitter release by phosphatidylinositol 3-kinase.
    Itakura M; Yamamori S; Kuwahara R; Sekiguchi M; Takahashi M
    J Neurochem; 2005 Jul; 94(2):502-9. PubMed ID: 15998300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation.
    Carricaburu V; Lamia KA; Lo E; Favereaux L; Payrastre B; Cantley LC; Rameh LE
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9867-72. PubMed ID: 12897244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New in-capillary electrophoretic kinase assays to evaluate inhibitors of the PI3k/Akt/mTOR signaling pathway.
    Nehmé R; Nehmé H; Saurat T; de-Tauzia ML; Buron F; Lafite P; Verrelle P; Chautard E; Morin P; Routier S; Bénédetti H
    Anal Bioanal Chem; 2014 Jun; 406(15):3743-54. PubMed ID: 24817345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A robust screen for inhibitors and enhancers of phosphoinositide-3 kinase (PI3K) activities by ratiometric fluorescence superquenching.
    Stankewicz C; Rininsland FH
    J Biomol Screen; 2006 Jun; 11(4):413-22. PubMed ID: 16490774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of δ-opioid receptor.
    Olianas MC; Dedoni S; Onali P
    Eur J Pharmacol; 2011 Jun; 660(2-3):341-50. PubMed ID: 21515255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.